Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 39 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Akriviadis, Evangelos  [Clear All Filters]
Journal Article
Papalavrentios, L., Sinakos E., Chourmouzi D., Hytiroglou P., Drevelegas K., Drevelegas A., et al. (2013).  3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease.. Hepatology. 58(1), 449-50.
Paschos, P., Ioakim K., Malandris K., Koukoufiki A., Nayfeh T., Akriviadis E., et al. (2021).  Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.. Anaerobe. 71, 102441.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.. Ann Gastroenterol. 28(3), 374-378.
Cholongitas, E., Goulis J., Arsos G., Birtsou C., Nakouti T., Papadopoulou S., et al. (2013).  Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis.. Clin Gastroenterol Hepatol. 11(7), 862-7.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Authors' reply.. Ann Gastroenterol. 28(4), 507.
Manolakopoulos, S., Kranidioti H., Goulis J., Vlachogiannakos J., Elefsiniotis J., Kouroumalis E. A., et al. (2015).  Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.. Ann Gastroenterol. 28(4), 481-6.
Cholongitas, E., Karatapanis S., Nakouti T., Birtsou C., Skorda L., Kouvelis I., et al. (2012).  Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?. Liver Int. 32(1), 172-3.
Papatheodoridis, G., Goulis J., Manolakopoulos S., Margariti A., Exarchos X., Kokkonis G., et al. (2014).  Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.. J Hepatol. 60(1), 62-8.
Kiapidou, S., Liava C., Kalogirou M., Akriviadis E., & Sinakos E. (2020).  Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?. Ann Hepatol. 19(2), 134-144.
Fotiadu, A., Gagalis A., Akriviadis E., Kotoula V., Sinakos E., Karkavelas G., et al. (2010).  Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease.. Pathol Int. 60(2), 87-92.
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Louvet, A., Thursz M. R., Kim D. Joon, Labreuche J., Atkinson S. R., Sidhu S. Singh, et al. (2018).  Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.. Gastroenterology. 155(2), 458-468.e8.
Cholongitas, Ε., Goulis I., Theocharidou E., Antoniadis N., Fouzas I., Giakoustidis D., et al. (2014).  Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience.. Hepatol Int. 8(1), 137-45.
Sinakos, E., Hytiroglou P., Chourmouzi D., & Akriviadis E. (2015).  Focal nodular hyperplasia in an individual with Abernethy malformation type 1b.. Dig Liver Dis. 47(12), 1089.
Cholongitas, E., Arsos G., Goulis J., Birtsou C., Haidich A-B., Nakouti T., et al. (2014).  Glomerular filtration rate is an independent factor of mortality in patients with decompensated cirrhosis.. Hepatol Res. 44(10), E145-55.
Imvrios, G., Vrochides D., Papanikolaou V., Fouzas I., Antoniadis N., Giakoustidis D., et al. (2011).  HCC influence on patient survival after liver transplantation for HDV cirrhosis.. Hepatogastroenterology. 58(110-111), 1654-8.
Cholongitas, E., Goulis J., Akriviadis E., & Papatheodoridis G. V. (2011).  Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.. Liver Transpl. 17(10), 1176-90.
Oikonomou, T., Goulis I., Soulaidopoulos S., Karasmani A., Doumtsis P., Tsioni K., et al. (2017).  High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 217-224.
Cholongitas, E., Papatheodoridis G. V., Goulis J., Vlachogiannakos J., Karatapanis S., Ketikoglou J., et al. (2015).  The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.. Ann Gastroenterol. 28(1), 109-117.
Dimopoulou, D., Dimitroulas T., Akriviadis E., & Garyfallos A. (2015).  Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis.. Rheumatol Int. 35(11), 1913-6.
Pachiadakis, I., Choksi S., Ilonidis G., Akriviadis E., & Goulis I. (2013).  Letter to the editor concerning the paper: Boltjes A, Op den Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients [Molecular Immunolog. Mol Immunol. 56(1-2), 129-30.
Lazaraki, G., Akriviadis E., Pilpilidis I., Parisi I., Tzilves D., & Tarpangos A. (2011).  Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia.. Am J Gastroenterol. 106(12), 2204-6.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Papanikolaou V., et al. (2014).  New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.. Transpl Int. 27(10), 1022-8.
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.
Goulis, I., Karatapanis S., Akriviadis E., Deutsch M., Dalekos G. N., Raptopoulou-Gigi M., et al. (2015).  On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.. Liver Int. 35(5), 1540-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές